|
|
|
|
|
| INSTANT REPLAY |
|
(Course AB0440)
| |
 |
In this Instant Replay, a nurse practitioner demonstrates ways to quickly and effectively screen for depression.
Reviewed by Kimberly Littrell, MS, ARNP, BC
Recorded Live:
Thursday, September 29, 2005 |
|
Supported by an educational grant from:
 |
|
|
|
|
| |
|
| OVERVIEW |
|
|
As primary care visits become shorter, how do
you fit one more thing into an already packed 15 minutes? In this Instant
Replay, a nurse practitioner will demonstrate ways to quickly and effectively
screen for depression. |
|
| | [Top] |
| OBJECTIVES |
|
|
Upon completion of this course, you should be able to: |
| |
-
Conduct an accurate assessment of a patient presenting with depressive signs and symptoms
-
Perform a differential diagnosis in a patient with signs and symptoms of depression
-
Describe strategies for effectively treating mood disorders
|
|
| | [Top] |
|
|
| | [Top] |
| TARGET AUDIENCE |
|
| These CE activities are designed for nurse practitioners as well as other healthcare providers who are involved in the care of patients with depression. |
|
| | [Top] |
| FACULTY DISCLOSURE |
|
|
|
 |
| Valerie A. Hart, EdD, APRN, CS
[BioSketch]
|
| Associate Professor of Nursing, University of Southern Maine; Private Psychotherapy Practice, Portland, Me |
| Disclosure: No financial relationships with a commercial party to disclose. |
|
|
 |
| Kimberly Littrell, MS, ARNP, BC
[BioSketch]
|
| President and Chief Executive Officer Promedica, Inc.; Adjunct Professor, College of Health Sciences Georgia State University, Atlanta, Ga |
| Disclosure: Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb, Janssen; Educational Grants: Bristol-Myers Squibb; Consultant: Bristol-Myers Squibb, AstraZeneca, Janssen, Solvay |
|
|
|
| | [Top] |
| CONFLICT OF INTEREST RESOLUTION |
|
As an ACCME accredited provider, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity.
All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.
Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose. |
|
| | [Top] |
| Accreditation
Statement |
| |
| Continuing Medical Education for Nurse Practitioners |
| These activities have been granted 1 contact hour(s) of continuing education (which includes .2 hours of pharmacology) by the American Academy of Nurse Practitioners, Program ID 0707301 |
| |
| Accreditation Period |
| These activities were initially published on August 1, 2005, were reviewed on July 31, 2007, and are eligible for credit through July 31, 2009. | |
|
|
|
| | [Top] |
| DISCLAIMER |
|
Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements. |
|
| | [Top] |
|
|
| | [Top] |
| CERTIFICATE FEES |
|
| This course certificate is FREE to qualified attendees. |
|
| | [Top] |
|
|
|
